Response of Neutrophils to Extracellular Haemoglobin and LTA in Human Blood System

EBioMedicine. 2015 Jan 13;2(3):225-33. doi: 10.1016/j.ebiom.2015.01.003. eCollection 2015 Mar.

Abstract

Background: Haemolytic infection lyses red blood cells, releasing haemoglobin (Hb) into the plasma. Although recent studies showed that immune cells recognize redox-active cytotoxic extracellular Hb (metHb) bound to pathogen-associated molecular patterns (PAMPs), currently available information is limited to experiments performed in defined conditions using single cell lines. Therefore, a systemic approach targeting primary whole blood cells is required to better understand the cellular immune defence against metHb and PAMPs, when under a haemolytic infection.

Methods: We investigated how human white blood cells, including neutrophils, respond to metHb and lipoteichoic acid (LTA) by measuring reactive oxygen species (ROS), signalling mediators (ERK and p38), NF-κB, cytokines, elastase secretion and cell activation markers.

Findings: metHb activates NF-κB in TLR2-expressing HEK293 cells but not in normal or TLR9-expressing HEK293 cells. Treatment of isolated neutrophils with metHb increased production of ROS and expressions of IL-8, TNFα, and CD11b, which were further enhanced by metHb + LTA complex. While LTA stimulated the survival of neutrophils, it caused apoptotic cell death when complexed with metHb. The activation of neutrophils by metHb + LTA was subdued by the presence of other types of white blood cells.

Interpretation: metHb and metHb + LTA complex are ligands of TLR2, inducing an unconventional TLR signalling pathway. Neutrophils are a highly sensitive cell type to metHb + LTA complex. During a haemolytic infection, white blood cells in the vicinity crosstalk to modulate neutrophil TLR-signalling induced by metHb and LTA.

Keywords: Extracellular haemoglobin; Haemolytic infection; Leukocytes; Lipoteichoic acid; Reactive oxygen species; Staphylococcus aureus; Toll like receptor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Death / drug effects
  • Cell Survival / drug effects
  • Cytokines / metabolism
  • HEK293 Cells
  • Humans
  • Inflammation / immunology
  • Inflammation / pathology
  • Leukocytes / drug effects
  • Leukocytes / metabolism
  • Lipopolysaccharides / metabolism
  • Lipopolysaccharides / pharmacology*
  • Methemoglobin / metabolism
  • Methemoglobin / pharmacology*
  • NF-kappa B / metabolism
  • Neutrophil Activation / drug effects
  • Neutrophil Activation / physiology*
  • Pancreatic Elastase / metabolism
  • Pathogen-Associated Molecular Pattern Molecules / metabolism
  • Signal Transduction
  • Teichoic Acids / metabolism
  • Teichoic Acids / pharmacology*
  • Toll-Like Receptor 2 / genetics
  • Toll-Like Receptor 2 / immunology
  • Toll-Like Receptor 2 / metabolism*

Substances

  • Cytokines
  • Lipopolysaccharides
  • NF-kappa B
  • Pathogen-Associated Molecular Pattern Molecules
  • TLR2 protein, human
  • Teichoic Acids
  • Toll-Like Receptor 2
  • lipoteichoic acid
  • Methemoglobin
  • Pancreatic Elastase